<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01863355</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0176</org_study_id>
    <nct_id>NCT01863355</nct_id>
  </id_info>
  <brief_title>Comparison of Analgesic Efficacy and Occurrence of Emesis Among Different Background Infusion and Bolus Administration Regimens of Fentanyl Based Intravenous Patient-controlled Analgesia in Patients After Laparoscopic Assisted Gastrectomy - a Randomized Blind Study -</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fentanyl based intravenous patient controlled analgesia(PCA)is popular method for
      postoperative pain control, but information regarding optimal dose of fentanyl in IV PCA is
      currently lacking. We thus determine appropriate dose of fentanyl (bolus dose and background
      infusion rate) for effective pain control with minimal side effects such as nausea and
      vomiting
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score(VAS) within 48hrs after surgery</measure>
    <time_frame>Pain socre after surgery 1) within 30min-6hrs, 2) within 6-24hrs, 3) within 24hrs-48hrs</time_frame>
    <description>Pain score after surgery within 48hrs after laparoscopic gastrectomy</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">225</enrollment>
  <condition>The Patients With Gastric Cancer Who Are Scheduled to Receive Laparoscopy Assisted Gastrectomy</condition>
  <arm_group>
    <arm_group_label>B0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(basal rate 0cc/hr, bolus 3cc, lockout time 10min)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(basal rate 1cc/hr, bolus 2cc, lockout time 10min)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BH</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>(basal rate 2cc/hr, bolus 1cc, lockout time 10min)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>B0 group: bolus 0.6mcg/kg without background infusion</intervention_name>
    <arm_group_label>B0</arm_group_label>
    <other_name>Fentanyl based intraveonus patient controlled analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BL group: bolus 0.4mcg/kg with background infusion rate 0.2mcg/kg/hr</intervention_name>
    <arm_group_label>BL</arm_group_label>
    <other_name>Fentanyl based intraveonus patient controlled analgesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BH group: bolus 0.2mcg/kg with background infusion rate 0.4mcg/kg/hr</intervention_name>
    <arm_group_label>BH</arm_group_label>
    <other_name>Fentanyl based intraveonus patient controlled analgesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 20 and 70

          -  ASA class I and II

          -  Gastric cancer patients who are scheduled to receive laparoscopic gastrectomy

        Exclusion Criteria:

          -  Cardiovascular disease(uncontrolled hypertension, unstable angina, congestive heart
             failure, etc.)

          -  Renal failure

          -  Liver failure

          -  Chronic drug or alcohol abuser

          -  Anti-cancer chemotherapy

          -  Chronic opioid use

          -  Use of antiemetics within 24hrs for nausea and vomiting
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kwan-woong Choi</last_name>
    <phone>(82) 2-2227-4613</phone>
    <email>sanctum@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kwan-woong Choi</last_name>
      <phone>(82) 2-2227-4613</phone>
      <email>sanctum@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2013</study_first_submitted>
  <study_first_submitted_qc>May 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2013</study_first_posted>
  <last_update_submitted>May 22, 2013</last_update_submitted>
  <last_update_submitted_qc>May 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

